Provention Bio, Inc. Annual Operating Income (Loss) in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Provention Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2022.
  • Provention Bio, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$40.2M, a 55.3% decline year-over-year.
  • Provention Bio, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$128M, a 10.9% decline year-over-year.
  • Provention Bio, Inc. annual Operating Income (Loss) for 2022 was -$128M, a 10.9% decline from 2021.
  • Provention Bio, Inc. annual Operating Income (Loss) for 2021 was -$116M, a 15.9% decline from 2020.
  • Provention Bio, Inc. annual Operating Income (Loss) for 2020 was -$99.7M, a 125% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$128M -$12.6M -10.9% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-29
2021 -$116M -$15.9M -15.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 -$99.7M -$55.3M -125% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-29
2019 -$44.4M -$17.6M -65.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$26.8M -$17.7M -193% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$9.14M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.